» Articles » PMID: 30102404

A PiRNA Utilizes HILI and HIWI2 Mediated Pathway to Down-regulate Ferritin Heavy Chain 1 MRNA in Human Somatic Cells

Overview
Specialty Biochemistry
Date 2018 Aug 14
PMID 30102404
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The piwi interacting RNAs (piRNAs) are small non-coding RNAs that specifically bind to the PIWI proteins, a functional requirement. The piRNAs regulate germline development, transposons control, and gene expression. However, piRNA-mediated post-transcriptional gene regulation in human somatic cells is not well understood. We discovered a human piRNA (piR-FTH1) which has a complementary sequence in the ferritin heavy chain 1 (Fth1) mRNA. We demonstrated that expression of piR-FTH1 and Fth1 are inversely correlated in the tested tumor cell lines. We found that piR-FTH1 negatively regulates the Fth1 expression at post-transcriptional level in triple negative breast cancer (TNBC) cells. Additionally, we confirmed that transfected piR-FTH1 knocks down the Fth1 mRNA via the HIWI2 and HILI mediated mechanism. piR-FTH1 mediated Fth1 repression also increased doxorubicin sensitivity by a remarkable 20-fold in TNBC cells. Since the current piRNA-mediated knockdowns of target mRNA are mostly reported in germ line cells, piRNA-mediated post-transcriptional gene regulation in somatic cells is rather unique in its application and mechanistically uses an alternative pathway to siRNA and miRNA. This work begins to lay the groundwork with a broader impact on treatment of various diseases that are linked to elevated levels of specific mRNAs which have a piRNA target.

Citing Articles

Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.

Benacka R, Szaboova D, Gulasova Z, Hertelyova Z Int J Mol Sci. 2025; 26(1.

PMID: 39795985 PMC: 11719911. DOI: 10.3390/ijms26010127.


Somatic piRNA and PIWI-mediated post-transcriptional gene regulation in stem cells and disease.

Patel M, Jiang Y, Kakumani P Front Cell Dev Biol. 2024; 12:1495035.

PMID: 39717847 PMC: 11663942. DOI: 10.3389/fcell.2024.1495035.


HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.

Hammad G, Magdy M, Aboushousha T, Abdelraouf A, Mamdouh S Asian Pac J Cancer Prev. 2024; 25(6):2123-2131.

PMID: 38918675 PMC: 11382836. DOI: 10.31557/APJCP.2024.25.6.2123.


piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian Cancer.

Yan Y, Tian D, Zhao B, Li Z, Huang Z, Li K Technol Cancer Res Treat. 2024; 23:15330338241249692.

PMID: 38706262 PMC: 11072069. DOI: 10.1177/15330338241249692.


Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells.

Garcia-Borja E, Siegl F, Mateu R, Slaby O, Sedo A, Busek P Biomark Res. 2024; 12(1):15.

PMID: 38303021 PMC: 10836005. DOI: 10.1186/s40364-024-00563-3.


References
1.
Keizer H, Pinedo H, Schuurhuis G, Joenje H . Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther. 1990; 47(2):219-31. DOI: 10.1016/0163-7258(90)90088-j. View

2.
Ku S, Jo S, Lee Y, Kim K, Kim S . Chemical and structural modifications of RNAi therapeutics. Adv Drug Deliv Rev. 2015; 104:16-28. DOI: 10.1016/j.addr.2015.10.015. View

3.
Faulkner G, Kimura Y, Daub C, Wani S, Plessy C, Irvine K . The regulated retrotransposon transcriptome of mammalian cells. Nat Genet. 2009; 41(5):563-71. DOI: 10.1038/ng.368. View

4.
Lee J, Schutte D, Wulf G, Fuzesi L, Radzun H, Schweyer S . Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet. 2005; 15(2):201-11. DOI: 10.1093/hmg/ddi430. View

5.
Castel S, Martienssen R . RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond. Nat Rev Genet. 2013; 14(2):100-12. PMC: 4205957. DOI: 10.1038/nrg3355. View